Liver Function Tests - an overview

Dr Matt & Dr Mike
17 Nov 202120:46

Summary

TLDR本视频由Dr. Matt主讲,深入探讨了肝功能测试(LFTs)的基本概念、为何需要进行这些测试以及如何解读测试结果。视频首先定义了肝功能测试作为血液生物标志物,用以评估肝脏功能。接着,通过实例解释了可能需要进行肝功能测试的情况,如患者有肝病史、黄疸症状、药物中毒风险或家族肝病史。最后,视频通过图解详细说明了如何通过肝功能测试结果判断黄疸的原因,以及肝功能障碍的两大类别:胆汁淤积(胆固醇排泄问题)和肝细胞损伤(肝脏本身的问题)。

Takeaways

  • 🧬 肝功能测试是通过血液生物标志物来评估肝脏是否正常工作的一种方法。
  • 🩸 常见的肝功能测试包括酶类(如AST、ALT、ALP、GGT)和肝脏产生的产物(如白蛋白、凝血酶原时间、胆红素)。
  • 📈 肝功能测试可能因为多种原因被要求进行,例如患者有肝病史、黄疸症状、药物或酒精使用史,或者属于高风险群体。
  • 🔍 肝功能测试结果异常可能指示肝脏损伤或疾病,或者是肝脏功能不全。
  • 🟠 黄疸是皮肤和黏膜出现黄色着色,通常是由于胆红素积累造成。
  • 🩸 胆红素是红细胞分解的产物,主要在肝脏中被处理和排泄。
  • 💡 通过肝功能测试可以区分黄疸的原因,如前肝源性(红细胞破坏增加)、肝内源性(排泄障碍)和后肝源性(胆汁排泄问题)。
  • 📊 碱性磷酸酶(ALP)和γ-谷氨酰转移酶(GGT)的升高通常表明胆汁排泄受阻,即胆道阻塞。
  • 🚨 AST和ALT的显著升高可能指示急性肝损伤,而轻微升高可能与慢性影响有关。
  • 🍺 AST相对于ALT的升高可能与酒精性肝病有关,而两者比例的变化也可能指示肝硬化。
  • 📉 肝脏功能不全时,白蛋白和凝血因子的产生会减少,同时胆红素的处理也会受到影响。

Q & A

  • 肝脏功能测试是什么?

    -肝脏功能测试是血液参数,也称为血液生化标志物,用于指示肝脏可能没有正常工作。

  • AST和ALT的区别是什么?

    -AST(天门冬氨酸氨基转移酶)和ALT(丙氨酸氨基转移酶)都是指示肝脏损伤的酶。AST主要存在于线粒体中,而ALT主要存在于细胞质中。在血液中,这两种酶的比例大约是1:1。

  • 为什么ALT比AST更特异于肝脏损伤?

    -ALT主要存在于肝细胞的细胞质中,因此当肝脏损伤时,ALT的水平会比AST更显著地升高,使其成为更特异于肝脏损伤的指标。

  • ALP和GGT在肝脏功能测试中的作用是什么?

    -ALP(碱性磷酸酶)和GGT(γ-谷氨酰转移酶)在肝脏功能测试中用于指示胆道阻塞或胆汁淤积。ALP的增加可能与肝脏外部的骨组织有关,而GGT的增加则更特异地指示肝脏问题。

  • 黄疸是如何产生的?

    -黄疸是由于血液中胆红素积累导致的,表现为皮肤和黏膜的黄染。胆红素是红细胞分解的产物,在肝脏中被代谢和排泄。

  • 如何区分黄疸的前肝性和后肝性原因?

    -前肝性黄疸通常与红细胞破坏增加有关,导致间接胆红素(未结合胆红素)水平升高。后肝性黄疸则与胆汁排泄障碍有关,导致直接胆红素(结合胆红素)水平升高。

  • 肝脏功能测试中的凝血因子和白蛋白有什么意义?

    -凝血因子和白蛋白是肝脏产生的产品,它们的水平可以反映肝脏的合成功能。如果这些水平低于正常范围,可能表明肝脏功能受损。

  • 肝脏功能测试可能因为哪些原因被要求进行?

    -肝脏功能测试可能因为患者有肝病史、黄疸、药物或毒物暴露史、家族肝病史、高风险群体筛查(如血液透析、病毒性肝炎暴露、药物滥用史)或疑似肝脏损伤的其他原因而被要求进行。

  • 肝脏细胞损伤时,AST和ALT水平的变化意味着什么?

    -如果AST和ALT水平显著升高(超过正常值的10倍),通常意味着有急性严重的肝脏炎症。如果水平升高较轻(约5倍),则可能表明是慢性肝脏损伤。

  • 肝脏功能测试中的胆红素水平变化指示了什么?

    -胆红素水平的变化可以指示肝脏在处理和排泄胆红素方面是否存在问题。胆红素水平的升高可能与肝脏损伤、胆道阻塞或红细胞破坏增加有关。

  • 如何通过肝脏功能测试判断是否存在胆汁淤积?

    -如果ALP和GGT水平升高,且直接胆红素水平也升高,这可能表明存在胆汁淤积。胆汁淤积可能是由于胆道阻塞或其他影响胆汁排泄的因素导致的。

Outlines

00:00

🧬 肝脏功能测试概述

本段介绍了肝脏功能测试(LFTs)的基本定义,它们是血液参数或生物标志物,用于评估肝脏是否正常工作。主要讨论了两类指标:一是肝脏释放的酶类,如AST、ALT、ALP、GGT,它们若显著升高可能表明肝脏受损;二是肝脏产生的物质,如白蛋白、凝血酶原时间和胆红素,它们若超出正常范围则可能表明肝脏功能异常。此外,还探讨了进行LFTs的原因,包括患者有肝病史、黄疸症状、药物或酒精使用史、家族肝病史、高风险人群筛查等。

05:01

💛 黄疸与胆红素

这段内容详细解释了黄疸的原因,即皮肤和黏膜出现黄色着色,这是由于胆红素积累造成的。胆红素是红细胞分解的产物,主要在肝脏中被处理和排泄。介绍了胆红素的生成、运输和代谢过程,以及如何通过LFTs中的胆红素水平来判断黄疸的原因。还讨论了肝脏的微观结构,即肝小叶,以及胆红素如何在肝细胞中被代谢和排泄。

10:02

📈 胆红素水平的异常原因

本段讨论了胆红素水平异常的不同原因,包括红细胞破坏增加(前肝源性)、肝脏排泄功能受阻(肝内源性)和胆汁排泄障碍(后肝源性)。详细解释了如何通过LFTs中的直接和间接胆红素比例来区分黄疸的类型,并探讨了可能导致胆红素水平升高的具体疾病和情况,如溶血性贫血、Gilbert综合症、胆道阻塞等。

15:05

🦠 肝细胞损伤与胆汁淤积

这部分内容聚焦于肝细胞损伤和胆汁淤积的问题。肝细胞损伤时,AST和ALT水平会上升,而胆汁淤积时,ALP和GGT水平会升高。解释了ALP和GGT在肝细胞膜上的活性增加的原因,以及如何通过这些指标来判断胆汁淤积。同时,讨论了肝细胞损伤的两种情况:急性损伤(如药物中毒、病毒感染)和慢性损伤(如脂肪肝、慢性肝炎)。还提到了肝细胞功能不全时其他参数的变化,如白蛋白和凝血因子的产生减少,以及胆红素处理和排泄问题。

20:05

📊 肝脏功能测试的综合理解

最后一段总结了肝脏功能测试的目的和意义,以及如何通过LFTs的结果来理解肝脏健康状况。强调了LFTs在诊断肝脏疾病、监测肝脏功能和指导治疗决策中的重要性。通过图表和示意图,帮助观众更直观地理解LFTs的各个方面,以及它们如何反映肝脏的生理和病理状态。

Mindmap

Keywords

💡肝功能测试

肝功能测试,也称为肝脏生化指标,是通过血液参数来评估肝脏是否正常工作的医学检测。视频主要介绍了这些测试的定义、为何需要进行这些测试以及如何解读测试结果。

💡

酶是生物体内催化化学反应的蛋白质,肝功能测试中的酶如AST、ALT、ALP(碱性磷酸酶)和GGT(γ-谷氨酰转移酶)的升高,可能指示肝脏损伤或疾病。

💡肝脏产物

肝脏产物指的是肝脏合成并释放到血液中的物质,如白蛋白和凝血因子。这些产物的水平可以反映肝脏的功能状态。

💡胆红素

胆红素是红细胞分解产生的一种黄色物质,肝脏负责将其结合并排出体外。胆红素水平的异常升高可能指示肝脏处理胆红素的能力受损。

💡肝细胞损伤

肝细胞损伤指的是肝脏细胞由于各种原因(如药物、病毒、酒精等)受到损害。AST和ALT的显著增加通常与肝细胞损伤有关。

💡胆汁淤积

胆汁淤积是指胆汁流出肝脏和被排出体外的过程中出现问题,导致胆汁在肝内积聚。ALP和GGT的升高通常与胆汁淤积有关。

💡黄疸

黄疸是一种由于胆红素水平升高导致皮肤和黏膜出现黄色的症状。它可能是肝脏功能障碍或胆红素代谢异常的表现。

💡酶活性

酶活性是指酶催化化学反应的能力。在肝功能测试中,特定酶的活性增加可能表明肝脏细胞损伤或胆汁流动受阻。

💡肝脏小叶

肝脏小叶是肝脏的基本结构单位,由肝细胞围绕中心静脉排列形成的六角形结构。肝脏小叶的结构和功能对于理解肝脏的生理和病理状态至关重要。

💡肝脏疾病

肝脏疾病是指影响肝脏功能的一系列病理状态,包括肝炎、肝硬化、肝脏肿瘤等。肝功能测试是评估肝脏疾病的重要手段。

💡溶血性贫血

溶血性贫血是一种由于红细胞过度破坏导致的贫血类型,这会增加肝脏处理胆红素的负担,可能导致胆红素水平升高。

Highlights

定义了肝功能测试(LFTs)为血液参数,用于指示肝脏可能功能不佳。

介绍了常见的肝脏酶,如AST、ALT、ALP、GGT,它们在肝脏损伤时会显著增加。

解释了肝脏产生的产品,如白蛋白、凝血酶原时间和胆红素,它们在肝功能异常时会表现出异常。

讨论了肝功能测试可能被要求的原因,如患者有肝病史或怀疑存在问题。

提到了药物可能导致的肝损伤,如对乙酰氨基酚(扑热息痛)和酒精使用。

强调了高风险群体的筛查,如输血、病毒性肝炎暴露或使用非法药物。

解释了黄疸作为肝功能测试的一个关键指标,是由于胆红素积累导致的皮肤黄染。

描述了胆红素的来源和在肝脏中的代谢过程。

讨论了肝功能测试结果异常的两大原因:胆汁淤积(胆汁排泄问题)和肝细胞损伤(肝脏本身的问题)。

解释了如何通过LFTs区分黄疸的前肝源性和后肝源性原因。

强调了ALP和GGT在诊断胆汁淤积中的重要性,因为它们在胆汁排泄受阻时会上升。

讨论了AST和ALT在诊断肝细胞损伤中的作用,以及它们在急性和慢性肝损伤中的不同表现。

指出了白蛋白和凝血酶原时间在肝功能不全时的下降,以及胆红素处理问题的指标。

解释了肝脏的解剖结构,如肝小叶和中央静脉,以及它们在肝功能中的作用。

讨论了胆红素在肝脏中的代谢过程,包括其在肝细胞中的结合和排泄。

描述了肝细胞损伤时,AST和ALT的释放和它们在血液中的比例。

解释了ALP和GGT在胆汁淤积中的升高,以及如何通过这些指标判断肝脏问题。

Transcripts

play00:00

hi i'm dr matt and welcome to this video

play00:01

on liver function tests also known as

play00:04

your liver chemistries in this video

play00:06

we'll firstly define what these tests

play00:08

are

play00:09

secondly we'll look at some examples of

play00:11

why they may be ordered and then thirdly

play00:13

we'll go through a schematic drawing to

play00:15

try to categorize and make sense why

play00:17

these may be deranged

play00:19

so starting with the definition so the

play00:21

liver function tests are basically blood

play00:24

parameters blood biomarkers that give an

play00:27

indication that liver may not be

play00:29

functioning as well as it should be so

play00:30

some examples that we'll go through

play00:33

firstly these are enzymes that are

play00:34

released from the liver

play00:36

number one in no order we have one

play00:39

that's called ast

play00:42

so that's aspartate transaminase

play00:45

alanine transaminase

play00:48

a lp

play00:50

alkaline phosphatase

play00:53

ggt

play00:54

gamma gluta transferase now these are

play00:56

all enzymes so that will give an

play00:58

indication if these are markedly

play01:00

increased there could be a possibility

play01:02

that liver is injured and releasing

play01:04

these as a result the next three are

play01:06

actually products that are produced by

play01:08

the liver so we have albumin

play01:11

which is a protein

play01:13

we have prothrombin thyme which is an

play01:16

indication of the clotting factors that

play01:17

are released from the liver

play01:19

and then lastly we have bilirubin

play01:23

which is

play01:24

something that's made outside the liver

play01:26

but the liver conjugates it to allow it

play01:28

to be excreted so these four first four

play01:31

are enzymes these are more to do with

play01:34

how the liver is functioning or working

play01:37

because albumin is made there the

play01:38

clotting proteins are made in the liver

play01:41

and the bilirubin is processed and

play01:43

conjugated in the liver so if these are

play01:46

outside their range it indicates that

play01:48

the liver isn't functioning whereas

play01:49

these enzymes indicate it might be

play01:52

diseased or injured

play01:54

so moving on to why

play01:57

may they be ordered firstly

play01:59

to look at maybe the patient has a

play02:01

history of liver disease or you are

play02:04

concerned that there might be a problem

play02:06

so for instance if the patient comes

play02:08

with jaundice this is a yellow

play02:10

discoloration you may want to have an

play02:12

exploration to figure out why it's

play02:14

caused so you might have a look at this

play02:16

panel

play02:17

you may be concerned that they've taken

play02:19

a medication so they've taken a poison

play02:21

or something that could cause liver

play02:22

injury hepatotoxic medications such as

play02:25

paracetamol

play02:29

in america this is acetaminophen or

play02:31

tylenol but in australia we call it

play02:33

paracetamol

play02:35

the patient may have a history of

play02:37

alcohol use

play02:40

or they may have a positive family

play02:42

history of so a known family history of

play02:45

something that may cause damage to the

play02:47

liver an example is

play02:49

hematochromatosis which is basically the

play02:51

way that iron is stored in the liver or

play02:54

elsewhere in the body and that can cause

play02:55

damage and disease to the liver

play02:58

next we might look at groups that are

play03:00

high risk so it's a screening tool for

play03:02

patients that may be in a high risk

play03:03

category this could be if they've had a

play03:05

transfusion

play03:07

a blood transfusion

play03:09

they've been exposed to

play03:11

viral hepatitis let's say

play03:16

or maybe they

play03:18

have used illicit drugs

play03:24

now moving to another cause this could

play03:25

be extra hepatic so this big certain

play03:27

things that are outside the liver that

play03:29

could impact the liver so examples here

play03:31

would be malignancy

play03:36

so this is cancer so cancer a common a

play03:38

place where the cancer can spread as

play03:40

secondary so this is metastasizing it

play03:43

can go to the liver which then would

play03:44

suggest that the liver will start to

play03:46

become dysfunctional and these may start

play03:48

to increase another example if the liver

play03:51

has been

play03:53

hypoxic so a low level of oxygen low

play03:55

level of blood flow so

play03:57

let's say shock a patient has a history

play03:59

of shock

play04:00

and therefore you're concerned that

play04:02

liver might be damaged through ischemia

play04:03

or hypoxic

play04:05

finally medication there might be

play04:06

certain medications that might cause

play04:09

injury so you want to get a baseline

play04:10

before you prescribe this medication

play04:12

examples could be methotrexate as i said

play04:14

paracetamol or vaporate so these are

play04:16

some examples so there you have it there

play04:19

are there are some reasons why a

play04:20

clinician might order lft is to get an

play04:23

idea of what is happening at the liver

play04:26

now we're going to have a look at that

play04:27

schematic

play04:28

diagram to again to break this down and

play04:30

make sense of them

play04:33

now we move to the third part of this

play04:34

video which is trying to make sense of

play04:36

why these numbers why the liver function

play04:39

tests may be out of range what i want to

play04:41

look at is if your patient has jaundice

play04:44

how can we figure out what is the cause

play04:46

of the jaundice by looking at the lfts

play04:48

and then finally the two biggest causes

play04:51

of the derangement of lfts cholestasis

play04:54

which means a problem with the way the

play04:56

bile is leaving the liver and being

play04:58

excreted or hepatic cellular injury

play05:00

which means there's a problem intrinsic

play05:03

to the liver itself

play05:04

so let's start with jaundice jaundice is

play05:07

a yellow discoloration of the skin the

play05:09

sclera the mucous membranes which is due

play05:12

to a buildup of bilirubin so the lft

play05:15

we're going to look for here is

play05:16

bilirubin

play05:19

okay and basically anything above 1.2

play05:23

milligrams per deciliter or per 100 ml

play05:27

now before we go on we just got to

play05:29

quickly make sense of where does

play05:31

bilirubin come from

play05:33

so bilirubin is the breakdown product of

play05:35

red blood cells red blood cells will

play05:37

last approximately 120 days once they

play05:40

get to that age they get destructed and

play05:43

killed within certain organs like the

play05:45

spleen the bone marrow or the liver

play05:47

themselves now when the red blood cell

play05:49

is broken down

play05:50

a lot of the parts will be recycled the

play05:52

iron gets taken back to the liver to be

play05:54

reformed into other constituents

play05:57

the protein the globulins will get made

play05:59

into amino acid pools but the heme

play06:02

component will get broken down

play06:04

phagocytosed by macrophages and

play06:07

essentially be made into bilirubin

play06:10

now i'm not going to go through all the

play06:12

steps

play06:13

mike has done a video on this so i

play06:14

encourage you to have a quick look at

play06:15

that if you haven't covered this before

play06:17

but the bilirubin in this case will what

play06:19

we call b

play06:21

unconjugated bilirubin which means it

play06:23

has to be carried

play06:25

with a protein called albumin so that's

play06:27

a complex that will get transported in

play06:29

the blood and taken to the liver

play06:33

before i get to the more detail what i

play06:36

want to draw your attention to is this

play06:38

histological unit of the liver there's

play06:40

about a million of these and these are

play06:42

called the liver lobules the liver

play06:44

lobules are these kind of hexagonal

play06:47

shaped

play06:48

sections of the liver that has in the

play06:51

center what we call a central vein which

play06:54

is the accumulation of blood that has

play06:56

diffused or percolated through all the

play06:58

hepatocytes and then all of this central

play07:01

vein blood will eventually accumulate

play07:03

and then leave the liver via the

play07:05

inferior vena cava

play07:07

but what blood does it receive well it

play07:10

gets arterial blood so about 20 percent

play07:13

of arterial blood

play07:14

is what goes through this lobule and the

play07:17

70 to 80 of blood is through the portal

play07:20

vein so those two bloods merge together

play07:23

as the sinusoid kind of go through these

play07:26

plates of cells called the parasite and

play07:29

what goes the opposite direction is the

play07:31

bile cannuculi which is like a river of

play07:34

bile that goes out towards the outer

play07:37

part of the lobule and all of these bile

play07:40

ducts will start to come together

play07:42

form the hepatic ducts which then become

play07:44

the common hepatic duct meets the cystic

play07:47

duct of the gallbladder and then we have

play07:49

the common bile duct that goes down to

play07:51

the duodenum

play07:52

so it's this unit that i want to refer

play07:54

you to specifically just one hepatocyte

play07:57

so just one of those black dots will

play07:59

focus in here now so this is one

play08:02

hepatocyte

play08:03

on the outside so this is the sinusoid

play08:06

so this is the combination of portal

play08:08

blood and

play08:09

arterial blood fuse in through

play08:12

the hepatocyte will grab things

play08:14

and metabolize and filter and

play08:17

do all the different functions that the

play08:19

liver cells does and everything it

play08:21

doesn't want it gets put into the bile

play08:23

conuculide to be excreted out of the

play08:26

liver but we're focusing on bilirubin

play08:28

here so bilirubin will be coming along

play08:31

in the systemic blood remember it's

play08:33

unconjugated so it's got albumin

play08:35

attached to it it gets transported

play08:37

across into the hepatocyte where the

play08:40

abdomen detaches and then this

play08:42

unconjugated bilirubin gets taken to an

play08:44

enzyme called uridine diphosphate

play08:47

glucosyl transferase or ugt what this

play08:51

enzyme essentially does it will add a

play08:53

group to it to make it lipid sorry to

play08:55

make it water-soluble this now makes it

play08:57

a conjugated bilirubin

play08:59

also known as

play09:01

direct bilirubin so we'll focus on db

play09:05

direct bilirubin from here this

play09:08

conjugated bilirubin can get

play09:10

excreted via a protein called mrp2 and

play09:14

be put into the bile where it gets

play09:16

excreted

play09:17

eventually leaving the liver

play09:20

as the bile duct goes down into the

play09:22

intestines where a lot of it will be

play09:24

metabolized by bacteria

play09:26

some of it metabolized in a way that it

play09:28

can be reabsorbed in the bowel with some

play09:31

of it coming back

play09:33

absorbed it back across and it does this

play09:35

big long loop

play09:38

the rest of it will get taken and put

play09:40

out into the faeces that's what gives

play09:42

the brown coloring some of it will

play09:44

continue on as conjugated bilirubin

play09:47

which can then get

play09:48

urinated out and then that can be

play09:50

cleared as well and the rest will just

play09:52

go in this cycle

play09:54

so now with that basis we need to figure

play09:57

out well what could cause the bilirubin

play10:00

to be increased

play10:02

so this first part if your patient comes

play10:05

to you with that yellowness you don't

play10:06

really know what the cause and if you

play10:09

were to do

play10:10

some of the lfts and just find that

play10:12

their bilirubin is high you still don't

play10:14

know what's causing it so let's try to

play10:17

figure some of this out

play10:18

the first category of causes is

play10:21

something that's causing an increasing

play10:23

amount of red blood cell destruction and

play10:25

this is what we call pre-hepatic

play10:29

so if you were to have a patient that

play10:31

has high amounts of red blood cell

play10:33

destruction so they've got some kind of

play10:35

anemia hemolytic anemia or some kind of

play10:38

problem with their um hemoglobin that

play10:40

could cause an increase in destruction

play10:42

that would increase the amount of

play10:43

hemoglobin coming for bilirubin coming

play10:45

to the liver or they may have a lot of

play10:47

hemorrhage hematoma that would also

play10:49

increase it but another thing that could

play10:51

increase it is this enzyme could be

play10:54

slightly

play10:55

sluggish it's not working as quickly as

play10:57

it could

play10:58

the common condition that that could

play11:00

lead to or could lead to that decrease

play11:02

in activity is gilbert syndrome so if

play11:04

you have that syndrome the patient has

play11:05

that syndrome this is not working so

play11:07

well so therefore the conjugation speed

play11:10

is going to be decreased and then you'll

play11:12

have a up in the uncon unconjugated so

play11:15

if you want to figure out whether

play11:16

they've got a pre-hepatic cause

play11:19

of their jaundice what you will do is

play11:21

you do a blood test and if you see that

play11:24

their total bilirubin is proportionally

play11:27

higher

play11:28

than their direct

play11:30

so these two should be in a ratio but if

play11:33

this one goes much higher to this one it

play11:35

would suggest that

play11:37

there's a problem pre-hepatically so it

play11:40

could be increased destruction or a

play11:42

problem with this enzyme

play11:44

now

play11:45

the other option

play11:46

now there is intra-hepatic causes but

play11:48

i'm going to leave it to kind of this

play11:50

part so

play11:52

if there's a problem with his excretion

play11:54

okay that would mean that

play11:57

the same the right amount of bilirubins

play11:59

come to the liver the liver is doing

play12:01

everything it's supposed to do it

play12:02

conjugates it spits it out into the into

play12:05

the bio caniculide but there's a problem

play12:07

downstream there's a blockage for some

play12:09

reason which means we go backwards so

play12:12

the bile builds back up that means the

play12:15

conjugated bilirubin comes back across

play12:17

and spills across into the blood and

play12:20

then we see it in the blood okay but

play12:23

with this post-hepatic cause

play12:26

in comparison to the pre-hepatic cause

play12:28

what we actually see is an increase in

play12:30

the direct

play12:32

proportionally to the total

play12:34

so it switches

play12:36

with the pre so the post hepatic so if

play12:39

it's a post hepatic cause

play12:41

you'll actually see a much higher amount

play12:44

or percentage of the direct

play12:46

in the total because you've conjugated

play12:49

it you've gotten rid of it but it's come

play12:51

back and then it's gone across into the

play12:53

blood okay so this is one way you can

play12:55

figure out

play12:57

what is leading to the jaundice

play12:59

and so as we said this is a post-hepatic

play13:01

cause which is essentially going to be

play13:03

the collostasis which we're going to go

play13:05

through now so the the remaining part of

play13:09

your lfts

play13:10

is to try to figure out is the cause due

play13:13

to a cholestasis so a problem with the

play13:15

excretion or a problem with the cell

play13:19

itself

play13:20

so let's have a look at this one to

play13:22

start with

play13:24

so let's assume that there is a blockage

play13:26

so there could be a stone

play13:28

in the bar duct or there could be a

play13:30

structure so it's narrowed or there

play13:32

could be a tumor down in the head of the

play13:33

pancreas

play13:35

causing the flow to be disrupted in any

play13:38

case the bi will come backwards so it

play13:40

will come back up and what you'll see is

play13:42

the bile acid will come across

play13:45

back into the hepatocyte

play13:47

now

play13:48

on the membrane the bile the biconicular

play13:52

side of the hepatocyte so this side of

play13:54

the membrane there is an enzyme here

play13:56

that can produce

play13:58

a number of other

play14:00

and

play14:00

what this is going to be

play14:02

is

play14:04

alp so that's the alkaline phosphatase

play14:07

and this is generated by that enzyme on

play14:09

that membrane so when it's exposed to

play14:12

increased amount of bile acid this

play14:14

enzyme will become more active which

play14:17

increases the alp which then is pushed

play14:20

across into the sinusoid which then goes

play14:23

into the central vein and the ivc and

play14:26

then in your blood so if you start to

play14:29

see an increase in alp

play14:33

so let's say you do your alp levels and

play14:36

you've got a big increase or two two

play14:38

arrows up of alp

play14:40

you have a suspicion that it's due to a

play14:43

cholestasis cause

play14:45

but an important point here is alp

play14:48

is not specific to the liver it's also

play14:51

found in the placenta it's also found in

play14:53

bone tissue so you need to be sure that

play14:56

it is actually from the liver so there's

play14:57

another enzyme that kind of works on

play14:59

that membrane as well and that's the g

play15:01

g t that's the gamma gluta transferase

play15:04

so you want to also look for that one

play15:07

and if that is also up which is kind of

play15:09

the same mechanism you'll see that one

play15:12

up as well and if you see ggt up with

play15:16

alp you are confident that it's

play15:19

a cholestasis cause particularly if your

play15:22

direct bilirubin is up as well okay now

play15:26

for whatever reason let's just say your

play15:27

alp was up but this was normal and there

play15:30

was nothing here

play15:32

you need to suspect that it's coming

play15:34

from somewhere else outside the liver

play15:36

for instance

play15:37

bone is a big one so osteoblasts when

play15:40

they're highly active they're releasing

play15:43

this enzyme so this could be recent

play15:45

fractures or certain conditions where

play15:47

there's maybe tumors in the bone or

play15:49

pages disease causing an increase in ap

play15:51

levels

play15:53

finally we're going to have a look at

play15:55

hepatocellular injury so i'll just clear

play15:58

this off quickly

play16:00

and the two big enzymes that you need to

play16:02

be aware of with a paracellular injury

play16:05

is ast

play16:07

and a l t

play16:10

an important thing just to remember

play16:12

the s here

play16:14

even though these are found in the liver

play16:16

the s

play16:18

the way i remember is also striated

play16:20

muscle so this can be found in cardiac

play16:22

muscle and skeletal muscles so it's not

play16:24

specific to the liver so sometimes

play16:26

problems with heart or or spleeder

play16:28

muscles could also increase ast so just

play16:31

be aware of that but the alt-l is

play16:34

specific l to liver so this is much more

play16:36

specific to liver

play16:39

in terms of asp

play16:40

asd the majority that 80 is found in the

play16:44

mitochondria

play16:48

whereas the majority of alt is found out

play16:51

in the cytoplasm just to reiterate that

play16:54

ast 80 is found in the mitochondria 20

play16:57

in the cytoplasm whereas the majority of

play16:59

the alts in the actual hepatocyte

play17:02

cytoplasm itself in terms of the ratio

play17:04

there's more ast in the cell than alt

play17:08

but this is

play17:09

diffused out quicker which means in the

play17:12

blood these two are about a one to one

play17:15

ratio so if you would a

play17:16

normal person and normal

play17:19

levels of these two they're about a one

play17:20

to one ratio

play17:22

okay so we've understood that ast and

play17:24

alt is more specific to the hepatocyte

play17:27

injury okay but how do we distinguish

play17:30

with what kind of injury well if the

play17:31

numbers are kind of above

play17:34

10 times what they normally are that's

play17:38

an indication that there is an acute

play17:40

injury

play17:41

and it's

play17:42

severe

play17:45

so this is inflammatory based so

play17:47

anything that's kind of causing

play17:49

hepatocell inflammation acutely and

play17:52

quite severely is going to raise the

play17:54

amount of these two

play17:56

significantly this could be due to

play17:59

paracetamol so the toxic effects a viral

play18:03

acute viral infection like hepatitis or

play18:07

hypoxic injury like there's not enough

play18:09

blood coming to the liver which is going

play18:11

to cause extreme inflammation causing

play18:14

these levels to go up a significant

play18:16

amount so this is more acute

play18:19

causes of liver injury if the number is

play18:22

only let's say five

play18:24

times increased it's more suggestive

play18:27

that it's a chronic effect

play18:30

okay so chronic effects this could be

play18:32

things like

play18:34

fatty liver which could be

play18:36

alcohol-based or non-alcohol based fatty

play18:38

liver a chronic viral hepatitis

play18:42

or certain medications over time

play18:45

it's important to distinguish though

play18:47

that ast

play18:49

seems to be more sensitive to alcohol

play18:54

the reason well the theory for why that

play18:56

could be

play18:57

is a combination of ethanol

play19:00

causes irritation to the mitochondria

play19:02

which causes it to spill out and go into

play19:05

the blood at a higher amount so the

play19:08

ast like we said it should be one to one

play19:11

it's a higher ratio with alcohol-induced

play19:14

injury so the ast could be higher or the

play19:17

other cause of ast being increased

play19:20

relative to alt is through more chronic

play19:23

fibrosis or cirrhosis that causes the

play19:26

flow the blood flow through the liver to

play19:28

be sluggish which then reduces the

play19:30

amount of ast that normally leaves which

play19:32

then increases its buildup so

play19:35

ast

play19:36

increased relative to alt in ratio is

play19:39

usually due to cirrhosis

play19:42

and alcohol

play19:45

finally

play19:46

because the hepatocyte in the

play19:48

hepatocellular injury they're not it's

play19:51

not functioning as well you're going to

play19:53

see those certain parameters like

play19:55

albumin album has been isn't being

play19:57

produced to its normal level same with

play19:59

the clotting proteins and also the way

play20:02

that the

play20:03

bi the way that the bilirubin is

play20:05

processed through the hepatocyte it's

play20:07

going to be diminished and they're going

play20:09

to see the changes a reduction in

play20:11

abdomen problems with clotting time so

play20:13

the clotting time increases and we see

play20:16

problems with the bilirubin processing

play20:18

that's outside pre-hepatic and

play20:20

post-hepatic if there's a problem

play20:21

intrinsic to the cell with the enzymes

play20:24

and the transport proteins that's going

play20:26

to play around with bilirubin secretion

play20:28

excretion as well

play20:30

so hopefully today you've seen

play20:33

what liver enzymes are what are the

play20:35

indications of why they will be ordered

play20:36

and then we've schematically moved

play20:39

through to try to make sense why each

play20:41

one of them may be increased or deranged

play20:44

outside their normal values

Rate This

5.0 / 5 (0 votes)

相关标签
肝功能测试肝脏健康医学教育临床诊断酶学指标黄疸原因肝损伤酒精性肝病肝炎药物影响健康筛查